HMGB1 and neoplasm: More specifically, the two hallmarks associated with immunogenic cell death, the secretion of adenosine triphosphate (ATP) from dying tumor cells and the nuclear to cytoplasmic translocation of high mobility group B1 (HMGB1), are the gold standards for accurately predicting the ICD-inducing capacity of therapeutic regimens such as chemotherapeutic agents.